-
Roche CEO joins alliance against abandoning COVID vaccine patents
Time of Update: 2021-05-21
"Earlier this month, the Biden government unexpectedly took an action to support a proposal made by the World Trade Organization (WTO) that would temporarily suspend patent rights for COVID-19 products.
-
Shijian Biologics Trop-2 ADC declares the sixth clinical application in China
Time of Update: 2021-05-21
On May 13th, the CDE official website showed that the application for the clinical trial of the recombinant humanized anti-Trop2 monoclonal antibody-SN38 conjugate of Shijian Bio/Toyo Pharmaceutical Co.
At present, there are more than 50 ADC drugs declared clinically in China, involving targets including HER2, TROP-2, CD30, c-Met, etc.
-
Review of Shanghai Pharmaceutical Cimetidine Tablets and Perindopril Tert-butylamine Tablets
Time of Update: 2021-05-21
On May 12, Shanghai Pharmaceuticals issued an announcement stating that its wholly-owned subsidiary received the "Notice of Approval of Supplementary Application for Drugs" issued by the State Food and Drug Administration regarding cimetidine tablets and perindopril tert-butylamine tablets (4mg, 2mg) , The above-mentioned drugs have passed the quality and efficacy consistency evaluation of generic drugs.
-
Ministry of Commerce: Support the high-quality development of Chinese medicine service export base
Time of Update: 2021-05-21
At the same time, it will also create a good international environment for traditional Chinese medicine and strengthen talent training and incentives.
At the same time, it will also create a good international environment for traditional Chinese medicine and strengthen talent training and incentives.
-
Administration | Research status of anti-motion sickness sustained and controlled release drugs
Time of Update: 2021-05-21
At present, most of the common anti-motion sickness drugs on the market are in common dosage forms, such as Phencynonate Hydrochloride Tablets, with the trade name of Fycerol; Difenidol Hydrochloride Tablets, with the trade name of Vertigo; Diphenhydramine Tablets, The product name is Cheng Yuning, also known as Yun Haining.
-
National Medical Insurance Administration: to establish and improve the "dual channel" of medical insurance negotiation drugs
Time of Update: 2021-05-21
Medicine medicine medicine pharmacy pharmacy pharmacy It is worth noting that the opinions clearly indicate that the negotiated drugs will be classified and managed, and the focus will be on drugs with high clinical value, urgent needs, and high costs into the "dual-channel" management.
-
Cologne's two major new products will be launched this year, has won 6 high-end generic drugs
Time of Update: 2021-05-21
Recently, Kelun’s celecoxib capsules and afatinib maleate tablets have updated their review status, and the four types of generic listing applications for the two products have entered "under approval", which is expected to usher in good news in the near future.
-
The latest inspection results of Anhui Food and Drug Administration announced 3 pharmaceutical companies to stop production on their own!
Time of Update: 2021-05-21
The contents of the announcement showed that a total of 8 pharmaceutical companies were inspected this time, all of which were manufacturers of traditional Chinese medicine decoction pieces.
, and Anhui Shengyuan Baicaotang Chinese Medicine Decoction Pieces Technology Co.
-
Astellas Prostate Cancer Drug Xtandi Receives MHRA Approval
Time of Update: 2021-05-21
CompilenewbornRecently, the British Medicines and Health Products Administration (MHRA) approved Astellas prostate cancer drug Xtandi (enzalutamide, enzalutamide) for the treatment of adult male patients with metastatic hormone-sensitive prostate cancer (mHSPC).
-
18 measures to support the high-quality development of Chinese medicine service export bases
Time of Update: 2021-05-21
and social capital, support base established for patients outside the portal to promote and optimize the foreign patients and their entourage to China 18 entry and exit procedures and other policy measures to support the Chinese medicine medicine services exports High-quality development of the base.
-
EU: AstraZeneca can delay the fulfillment of the vaccine contract but needs to deliver 120 million doses by the end of June
Time of Update: 2021-05-21
On May 11, an attorney representing the European Union revealed on Tuesday that the European Union agreed to postpone the implementation of the new crown vaccine contract by AstraZeneca for three mont
-
Announcement of the State Food and Drug Administration on the revision of the instructions of Xiaoyan and Analgesic Ointment
Time of Update: 2021-05-21
On May 12, the State Food and Drug Administration issued an announcement, deciding to uniformly revise the [Adverse Reactions], [Contraindications] and [Precautions] items in the instructions of the anti-inflammatory analgesic ointment.
Attachment: Revision requirements for the instructions of anti-inflammatory analgesic ointment
-
East China's 2 billion varieties will be approved. Hengrui and Hisun have begun to seize the market
Time of Update: 2021-05-21
At present, only Hengrui and Hisun have won approvals for domestic pharmaceutical companies, and the combined market share of the two major domestic drugs is also close to 40%.
-
Vigorously develop the scale of the Chinese medicine market or usher in a new wave of growth
Time of Update: 2021-05-21
Medical Network News on May 14 Vigorously develop traditional Chinese medicine On the afternoon of May 12, the general secretary who was inspecting in Nanyang City, Henan Province successively came to the Medical Sacred Shrine and Nanyang Medicine Yibao Wormwood Products Co.
-
The first generic drug of 4 billion blockbuster varieties has come to the market and the competition is fierce!
Time of Update: 2021-05-21
Medical Network News on May 14 Heavy variety, the first imitation is nearly On May 12, the official website of the Center for Drug Evaluation of the National Medical Products Administration showed that Jiangsu Wanbang Biochemical 's application for the listing of generic drugs for Ochinib mesylate tablets has been accepted, and the first imitation is expected.
-
Will Pfizer return to the top 1 pharmaceutical company with its $26 billion sales blessing?
Time of Update: 2021-05-21
S. dollars, while Pfizer predicts that the new crown vaccine’s annual sales will reach 26 billion U.
If it meets sales expectations, Moderna's new crown vaccine will also smoothly rank among the top 5 best-selling drugs in 2021.
-
Junshi Bio: The clinical trial application of JS103 injection was approved
Time of Update: 2021-05-21
Gout is a crystal-associated joint disease caused by monosodium urate deposition and is directly related to hyperuricemia.
Gout and related diseases caused by hyperuricemia are high in China.
One of the chronic diseases, so the development of JS103 is expected to bring more treatment options to patients.
-
Biotech OX40 monoclonal antibody BAT6026 was approved for clinical use
Time of Update: 2021-05-21
On May 10, Biotech announced that its fully human anti-OX40 monoclonal antibody BAT6026 clinical trial application has obtained NMPA's default approval, and it intends to carry out clinical research on the treatment of advanced solid tumors.
-
1 billion blood lipid-lowering varieties "fighting"!
Time of Update: 2021-05-21
Medical Network News on May 13 A few days ago, the official website of the State Food and Drug Administration showed that simvastatin tablets from Sichuan Hairong Pharmaceutical of Yangtze River Pharmaceutical Group, simvastatin tablets from Shanghai Xinyi Wanxiang Pharmaceutical, and Xin from Hainan Hailing Chemical Pharmaceutical Vastatin tablets were approved on the same day as supplementary applications.
-
Beijing Biochem Ivabradine Hydrochloride Tablets Will Be Approved
Time of Update: 2021-05-21
According to the Insight database, there are currently 3 domestic pharmaceutical companies in the process of approval of the generic drugs of this variety.
